Atraric acid
Atraric acid derivatives as a new chemical lead structure for novel therapeutic compounds as AR antagonists, that can be used for prophylaxis or treatment of prostatic diseases. It inhibits PTP1B activity in a dose-dependent manner with IC50 values of 51.5 uM, suggest that atraric acid has potential to treat diabetes.
Product Specifications
CAS Number
4707-47-5
Purity
>98% (HPLC)
Solubility
DMSO:10 mM
Smiles
CC1=CC (=C (C (=C1C (=O) OC) O) C) O
Molecular Formula
C10H12O4
Molecular Weight
196.2
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog